Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00122421 · ClinicalTrials.gov registry record · NA
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT00122421: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT00122421 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00122421, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients.
Primary Outcome
aspirin use, ace inhibitor use, a1c measurement
Interventions
- BEHAVIORAL Pharmacist recommendations to primary care providers
- OTHER pharmacist recommendations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00122421 record still lists
NCT00122421 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Pharmacist recommendations to primary care providers is the first listed.
NCT00122421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00122421 about?
NCT00122421 is a clinical study titled "The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients". The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care provider...
What is the current status of trial NCT00122421?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2003-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00122421?
The interventions under investigation include: Pharmacist recommendations to primary care providers (BEHAVIORAL), pharmacist recommendations (OTHER).
Who is sponsoring clinical trial NCT00122421?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00122421's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia